Recent evidence suggests that branching pathways of sphingolipid metab
olism may mediate either apoptotic or mitogenic responses depending on
the cell type and the nature of the stimulus. While ceramide has been
shown to be an important regulatory component of apoptosis induced by
tumor necrosis factor a and the Fas ligand, sphingosine-l-phosphate (
SPP), a further metabolite of ceramide, has been implicated as a secon
d messenger in cellular proliferation and survival induced by platelet
-derived growth factor, neuronal growth factor, and serum. SPP protect
s cells from apoptosis resulting from elevations of ceramide. Inflamma
tory cytokines stimulate sphingomyelinase, but not ceramidase, leading
to accumulation of ceramide, whereas growth signals also stimulate ce
ramidase and sphingosine kinase leading to increased SPP levels. We pr
opose that the dynamic balance between levels of sphingolipid metaboli
tes, ceramide, and SPP and consequent regulation of different members
of the mitogen-activated protein kinases (JNK versus ERK) family is an
important factor that determines whether a cell survives or dies.